UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012293 |
|---|---|
| Receipt number | R000014362 |
| Scientific Title | Neoadjuvant radiation therapy concurrent with S-1 followed by systemic Gemcitabine therapy for Borderline resectable pancreatic cancer patients; A phase2 study |
| Date of disclosure of the study information | 2013/11/15 |
| Last modified on | 2017/08/07 08:50:43 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/11/14 14:04:05 | ||
| 2 | Update | 2016/05/14 14:42:27 | Name of primary person or sponsor Organization |
|
| 3 | Update | 2016/05/14 14:43:06 | Recruitment status |
|
| 4 | Update | 2017/08/07 08:50:43 | Recruitment status Last follow-up date Date of closure to data entry |
